FDA has approved a combination of the generic drugs naltrexone and bupropion (Contrave) for chronic weight management in obese adults (body mass index [BMI] >30 kg/m2). This combination agent has also been approved for use in those patients who are overweight (BMI >27 kg/m2) and...
The FDA has approved a new use for AstraZeneca’s Farxiga (dapagliflozin) to reduce risk of cardiovascular death and hospitalisation with heart failure in adults with reduced ejection fraction heart failure, with or without type 2 diabetes.
FDA Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high chole...
Previously approved medications that have gained new FDA approval for the treatment of additional medical conditions.
Zepbound™ (tirzepatide) injection is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥ 30 kg/m2), or overweight (BMI ≥ 27 kg/m2) with at least one weight-related comorbid conditi...
Despite the drugs effectiveness, it does have a serious side effect called a cytokine release syndrome, the FDA said. That's when theimmune systemgoes into overdrive, triggering symptoms like a rash, a rapid heartbeat and low blood pressure. ...
The FDA approved Eli Lilly's drug Zepbound for weight loss.Eli Lilly "In light of increasing rates of both obesity and overweight in the United States, today's approval addresses an unmet medical need," the FDA's Dr. John Sharretts, director of the agency's Division of Diabetes, Lipid ...
In addition to Contrave, the FDA has approvedQsymia from Vivus Inc.andBelviq from Arena Pharmaceuticals Inc.Sales of the drugs, once considered potential billion-dollar sellers, have been below expectations because of limited insurance coverage and high costs for patients. ...
It's not unusual for children with DS to be on three or four antiepileptic drugs (AEDs), said Galer. But even with polypharmacy, seizures remain poorly controlled in most patients. The antiepileptic drug (AED) stiripentol was approved by the US Food and Drug Administration (FDA) in 2018 for...
Obesity is associated wit... GE Sonnenberg,G Matfin,RR Reinhardt - 《British Journal of Diabetes & Vascular Disease》 被引量: 17发表: 2007年 FDA Approval of Obesity Drugs Given the obesity epidemic, patients and physicians are in need of safe and effective treatments. Companies are responding...